Active Ingredient: LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Proprietary Name: LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 300MG;300MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N022344
Product Number: 001
Approval Date: May 15, 2018
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status:
Discontinued
Patent and Exclusivity Information
